FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,183 resources

Source: Text:

By Version

By Authority

  • none: 1,983
  • hl7: 12,200

 

Start Prev Rows 600 - 800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.100.jsonFamilial Hypercholesterolemiaactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.102.jsonRhabdomyolysisactive2017-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.107.jsonLow Intensity Statin Therapyactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.12.jsonLiver Diseaseactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.13.jsonRhabdomyolysisactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.19.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2025-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.20.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.21.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.22.jsonLiver Disease ICD9active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.37.jsonStable and Unstable Anginaactive2025-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.39.jsonCerebrovascular Disease Stroke or TIAactive2023-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.41.jsonIschemic Heart Disease or Related Diagnosesactive2025-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.42.jsonLiver Diseaseactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.43.jsonLiver Diseaseactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.44.jsonCerebrovascular Disease Stroke or TIAactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.46.jsonIschemic Heart Disease or Related Diagnosesactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.47.jsonStable and Unstable Anginaactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.501.jsonOverweight or Obeseactive2025-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.502.jsonOverweight or Obeseactive2018-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.512.jsonElevated Blood Pressure Readingactive2019-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.513.jsonElevated Blood Pressure Readingactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.514.jsonFinding of Elevated Blood Pressure or Hypertensionactive2019-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.515.jsonBariatric Proceduresactive2024-02hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.517.jsonAge related macular degeneration intermediate dryactive2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.518.jsonOphthalmologist visitactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.519.jsonPosterior vitreous detachment (PVD)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.521.jsonOphthalmoscopic examactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.523.jsonOpthalmoscopic exams with Scleral Depressionactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.525.jsonReferral (ophthalmology)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.526.jsonRetina Ultrasoundactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.527.jsonRetina visualization inadequateactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.528.jsonRefusal or Noncompliance with treatmentactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.529.jsonVitreous hemorrhageactive2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.530.jsonVitreous hemorrhageactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.536.jsonMacula examinationactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.539.jsonFluorescein angiographyactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.541.jsonOptical coherence tomography (OCT)active2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.542.jsonIntravitreal injectionactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.543.jsonBevacizumab injectionactive2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.544.jsonRanibizumab injectionactive2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.545.jsonAflibercept injectionactive2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.552.jsonUveitisactive2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.553.jsonUveitisactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.554.jsonPost Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edemaactive2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.555.jsonMacular edemaactive2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.556.jsonCorticosteroids for Injectionactive2024-06hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.557.jsonCorticosteroids for Injectionactive2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.560.jsonTonometryactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.561.jsonIntraocular pressureactive2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.571.jsonRetinal Vein Occlusion Related Macular Edemaactive2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.576.jsonVitreous hemorrhageactive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.580.jsonIntravitreal and Periocular Injectionsactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.581.jsonIntravitreal and Periocular Injectionsactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.582.jsonCorticosteroids for Injectionactive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.583.jsonEndophthalmitis in the Right Eyeactive2020-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.584.jsonEndophthalmitis in the Left Eyeactive2020-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.585.jsonPanophthalmitis in the Right Eyeactive2020-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.586.jsonPanophthalmitis in the Left Eyeactive2020-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.587.jsonLost to follow upactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.588.jsonUveitisactive2020-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.610.jsonScleral depressed examactive2020-03hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.611.json3 Mirror Goldmann examactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.612.jsonScleral depressed examactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.615.jsonPhysical Disabilityactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.616.jsonFinancial difficultyactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.617.jsonVitreous exam findingsactive2020-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.619.jsonScleral depressed examactive2020-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.629.jsonPost operative follow upactive2020-07hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.67.jsonBreastfeedingactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.69.jsonStable and Unstable Anginaactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.70.jsonIschemic Heart Disease or Related Diagnosesactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.71.jsonCerebrovascular Disease Stroke or TIAactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.73.jsonBreastfeedingactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.85.jsonFamilial Hypercholesterolemiaactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.89.jsonRhabdomyolysisactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.9.jsonOutpatient Encounters for Preventive Careactive2019-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.91.jsonFamilial Hypercholesterolemiaactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.93.jsonHypercholesterolemia ICD 9active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.97.jsonHigh Intensity Statin Therapyactive2024-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1047.98.jsonModerate Intensity Statin Therapyactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1056.50.jsonHIV Lab Testsactive2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1056.51.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1056.52.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1056.53.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1056.71.jsonHuman Immunodeficiency Virus (HIV) Viral Loadactive2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.10.jsonARBs (Angiotensin Receptor Blockers)active2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1000.jsonOIA_V2_GLP1s_RxNormsactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1001.jsonOIA_V2_PCSK9s_RxNormsactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1002.jsonOIA_RFs_Secondary_Prevention_ICD10active2025-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1003.jsonOIA_RFs_Secondary_Prevention_SNOMEDactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1004.jsonOIA_RFs_Secondary_Prevention_CPTactive2025-02hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1005.jsonOIA_RFs_Secondary_Prevention_ICD_SM_CPTactive2025-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1006.jsonOIA_Asthma_COPD_Combo_Medsactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1007.jsonOIA_Asthma_COPD_Combo_Meds_SABA_SAMAactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1008.jsonOIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICSactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1009.jsonPAE_Patient_Conditionsactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1012.jsonPAE Conditions Shortactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1016.jsonOIA_TEST_VSactive2025-03hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1017.jsonTriptan Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1018.jsonNSAID Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1019.jsonStatin Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1021.jsonPenicillin Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1022.jsonMacrolide Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1023.jsonQuinolone Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1025.jsonBeta blocker Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1026.jsonACE inhibitor Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1027.jsonARB Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1028.jsonSulfonylurea Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1030.jsonDPP4i Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1031.jsonGLP1RA Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1032.jsonBeta blocker allergy intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1033.jsonSGLT2i Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1034.jsonMRA Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1036.jsonMeglitinide Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1037.jsonAlpha glucosidase inhibitor Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1038.jsonTZD Allergy NDFRTactive2025-04hl7fhir
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1041.jsonHemoglobinactive2025-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1042.jsonHematocritactive2025-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1043.jsonAnemia for Erythropoesis Simulating Agents I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1044.jsonAnemia for Erythropoesis Simulating Agents SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1045.jsonAnemia for Erythropoesis Simulating Agentsactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1046.jsonAZT Medsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1047.jsonFerritinactive2025-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1048.jsonKnee pain I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1049.jsonKnee pain SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.105.jsonconditions_heartfailureactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1050.jsonKnee painactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1051.jsonKnee decreased ROM SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1052.jsonKnee effusion I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1054.jsonKnee effusionactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1055.jsonKnee crepitus SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1056.jsonOIA_Antiemeticsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1057.jsonOIA_PDE5isactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1058.jsonOIA_Vitaminsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1059.jsonOIA_Plavixactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1061.jsonOIA_Oral_Contraceptivesactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1063.jsonOIA_Topical_Steroidsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1064.jsonOIA_Cough_Cold_Medsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1065.jsonAntiperspirant aluminum saltsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1066.jsonAntiperspirant anticholinergicsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1067.jsonAntieplieptic medicationsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1068.jsonAntidepressant medicationsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1069.jsonUrinary incontinence SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1070.jsonUrinary incontinence I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1071.jsonUrinary incontinenceactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1073.jsonHemifacial spasm SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1074.jsonHemifacial spasm I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1075.jsonHemifacial spasmactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1076.jsonSpasmodic dysphonia SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1077.jsonPhysical therapy procedure SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1078.jsonOccupational therapy SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1079.jsonHyperhidrosis SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1080.jsonHyperhidrosis I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1081.jsonHyperhidrosisactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1082.jsonTic disorder I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1083.jsonTic disorder SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1084.jsonTic disorderactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1085.jsonEsophageal achalasia SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1086.jsonEsophageal achalasia I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1087.jsonEsophageal achalasiaactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1088.jsonET propanolol or primidoneactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1089.jsonET topiramate alprazolam or gabapentinactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.109.jsonCKD stage4above I10active2024-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1090.jsonBlephraospasm SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1091.jsonBlepharospasm I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1092.jsonBlepharospasmactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1093.jsonStrabismus SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1094.jsonStrabismus I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1095.jsonStrabismusactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1096.jsonOveractive bladder SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1097.jsonOveractive bladder I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1098.jsonOveractive bladderactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1099.jsonMovement disorders SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.110.jsonCKD stage4above SCTactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1100.jsonMovement disorders I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1101.jsonMovement disordersactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1102.jsonLateral epicondylitis SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1103.jsonLateral epicondyltisis I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1104.jsonLateral epicondylitisactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1105.jsonPlantar fasciitis SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1106.jsonPlantar fasciitis I10active2025-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1107.jsonPlantar fasciititsactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1108.jsonCardiac CT SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1109.jsonCardiac CT CPTactive2025-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.111.jsonCKD stage4aboveactive2024-06hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1111.jsonCardiac CTactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1112.jsonCardiac MRI SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1113.jsonCardiac MRI CPTactive2025-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1114.jsonCardiac MRIactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1115.jsonCT Angiography of Coronary Artery SCTactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1116.jsonCT Angiography of Coronary Artery CPTactive2025-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.1117.jsonCT Angiography of Coronary Arteryactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.120.jsonDiabetic ketoacidosis SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.121.jsonDiabetic ketoacidosisactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.146.jsonLong Acting Muscarinic Antagonists (LAMA)active2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.159.jsonconditions_COPD I10active2024-08hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.175.jsonAsthmaactive2025-05hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.184.jsonDigTx Virtual Reality Contraindications Visual Impairmentactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.186.jsonBeta blockers GDMT for heart failureactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.188.jsonmedications_heart failureactive2024-12hl7vsac